Standout Papers

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma 2021 2026 2022 2024560
  1. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma (2021)
    Andrew Menzies‐Gow, Jonathan Corren et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 22

Citing Papers

The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma
2024 Standout
Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healing
2024 Standout
1 intermediate paper

Works of Primal Kaur being referenced

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
2021 Standout
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma
2020

Author Peers

Author Last Decade Papers Cites
Primal Kaur 693 306 263 621 366 32 1.7k
Gero Massenkeil 374 650 88 166 271 56 1.9k
Marrie C.A. Bruin 448 194 271 87 158 51 1.8k
Arthur J. Provisor 161 370 264 163 586 40 1.7k
Frank B. Vasey 672 73 34 98 202 62 1.9k
WE Fibbe 758 496 142 113 168 36 1.9k
Joel M. Rappeport 906 292 96 139 107 48 2.1k
Meena Thayu 239 452 190 167 491 59 2.0k
Nicole Graf 72 132 27 470 335 38 1.5k
J O'donnell 379 86 42 121 260 61 1.8k
Gunnar Öberg 309 448 164 79 119 59 2.1k

All Works

Loading papers...

Rankless by CCL
2026